Trials / Recruiting
RecruitingNCT04843215
A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
A Phase III, Multicenter, Prospective, Randomized, Controlled Clinical Trial Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer (TOP-GC)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 950 (estimated)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase III, multicenter, prospective, randomized, controlled clinical trial to evaluate the impact of omentectomy for advanced gastric cancer on patient survival.
Detailed description
In order to evaluate the impact of omentectomy for advanced gastric cancer on patient survival, we designed this trial. Patients who received curative gastrectomy were divided into two groups based on whether they underwent omentectomy. The purpose of this study is to prove the non-inferiority of omentum preservation compared with omentectomy in patients with T3-T4a gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Type of omentectomy | Experimental group D2 radical gastrectomy with partial omentectomy. Partial omentectomy with preservation of the greater omentum at \>3 cm from the gastroepiploic arcade.Control group with total omentectomy. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2023-12-31
- Completion
- 2026-12-31
- First posted
- 2021-04-13
- Last updated
- 2021-05-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04843215. Inclusion in this directory is not an endorsement.